Artigo
Revisado por pares
Pimavanserin evaluated by the FDA
2018; Elsevier BV; Volume: 391; Issue: 10132 Linguagem: Inglês
10.1016/s0140-6736(18)31002-x
ISSN1474-547X
Autores Tópico(s)Mosquito-borne diseases and control
ResumoThe US Food and Drug Administration is conducting an evaluation of available evidence about pimavanserin. Paul Webster reports.
Referência(s)